Monthly Archives: November 2026

Dermorphin Research: Frog-Skin Opioid Peptide Analysis

Dermorphin is a naturally occurring heptapeptide opioid agonist originally isolated from the skin secretions of the South American tree frog Phyllomedusa sauvagii, with the sequence H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2; it signals primarily through μ-opioid receptors and is scientifically notable as one of the early vertebrate peptides shown to contain a D-amino acid residue essential for activity (Broccardo et […]

Semax Peptide: Neuroprotection and Neurotrophin Review

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro, MEHFPGP) whose N-terminal Met-Glu-His-Phe segment corresponds to ACTH residues 4-7, extended by Pro-Gly-Pro for stability while lacking the parent hormone’s steroidogenic activity. Research has examined Semax as a neuroprotective and neurotrophin-modulating agent, particularly in cerebral ischemia models where published work documents BDNF/TrkB-related transcription effects. Developed in Russia as a […]

Selank Peptide: Tuftsin-Derived Anxiolytic Mechanism Review

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, TKPRPGP) built from the tuftsin sequence Thr-Lys-Pro-Arg at its N-terminus, extended by a Pro-Gly-Pro segment studied for stability. Developed in Russian peptide laboratories, Selank has been investigated for anxiolytic and mild activating effects, with mechanistic work examining GABAergic gene-expression changes and enkephalin interactions rather than a benzodiazepine binding site. […]

Sermorelin Acetate: PK, Diagnostic History & Stability Notes

Sermorelin acetate is the acetate salt of the 29-residue N-terminal fragment of human growth hormone-releasing hormone, commonly written GHRH(1-29)NH2 (sequence YADAIFTNSYRKVLGQLSARKLLQDIMS-NH2; CAS 86168-78-7; free-base molecular weight near 3,357.9 Da). It binds the pituitary GHRH receptor (GHRHR) and stimulates pulsatile endogenous growth hormone (GH) secretion. Peer-reviewed reviews describe it as the shortest synthetic peptide that retains […]

Follistatin Research: Myostatin Antagonist Biology Overview

What Is Follistatin? Follistatin (FST) is an endogenous secreted glycoprotein encoded by the FST gene that acts as a high-affinity binding antagonist of mature TGF-β superfamily ligands—principally myostatin (GDF-8) and activins—physically preventing those ligands from engaging the ActRIIB receptor and activating SMAD signaling. Initially characterized as an activin-binding regulator in reproductive biology, it entered muscle […]

CJC-1295 With DAC: Long-Acting GHRH Analog Evidence Profile

CJC-1295 With DAC is a long-acting synthetic GHRH-receptor agonist: a modified GHRH(1-29) sequence carrying a maleimide-based drug-affinity-complex (DAC) linker that binds circulating albumin after subcutaneous administration, greatly extending circulation time compared with native GHRH or the no-DAC variant. It stimulates the pituitary to secrete endogenous growth hormone (GH) via the GHRH receptor (GHRHR). Unlike the […]

GDF-8 Myostatin: The Muscle-Brake Ligand Research Overview

What Is GDF-8? GDF-8 (growth differentiation factor 8), better known as myostatin, is a secreted member of the transforming growth factor-beta (TGF-β) superfamily that functions as a negative regulator of skeletal muscle mass; it signals through the activin type IIB receptor (ActRIIB) and downstream SMAD proteins to restrain myoblast proliferation and satellite-cell activation. It was […]

TB-500 Research: Actin Biology and Clinical History

What Is TB-500? TB-500 is the laboratory shorthand for the synthetic acetate form of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid actin-binding protein expressed widely across tissues, including platelets, endothelial cells and epithelial surfaces. It was developed for research purposes to study cytoskeletal regulation, cell migration and tissue remodeling; in published work Tβ4 reversibly sequesters […]

CJC-1295 + Ipamorelin Blend: Dual-Pathway Research Guide

The CJC-1295 no DAC 5 mg + IPA 5 mg blend is a two-component research mixture combining a modified GHRH(1-29) analog (CJC-1295 No DAC) with the selective ghrelin-receptor agonist ipamorelin (IPA). The two components engage complementary pituitary signaling routes: GHRHR/Gs-cAMP and GHS-R1a/Gq-calcium, which published secretagogue reviews describe as the mechanistic basis for additive growth-hormone (GH) […]

DSIP Peptide: Sleep EEG and HPA-Axis Research Review

Delta sleep-inducing peptide (DSIP) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) isolated from rabbit cerebral venous blood in the 1970s and studied as a sleep-EEG modulator and HPA-axis regulator. Unlike receptor-defined sedative drugs, DSIP has no single established receptor; its name reflects an early slow-wave EEG observation rather than a proven function. Published work spans animal […]